Lilly Systems Biology is now Lilly Singapore Centre for Drug Discovery.

As a leading, innovation-driven pharmaceutical corporation, we believe that the best way to find the next generation of drugs is to use the next generation technologies. And, we have expanded our drug discovery and scientific computational research centre in Singapore to do just that.

Lilly Singapore Centre for Drug Discovery focuses on drug discovery based on adult stem cell and epigenetic research in the areas of cancer and metabolic disorders. The Centre also conducts biomarker discovery in these areas, and scientific computational research and development in support of therapeutic areas of interest to Lilly.

Lilly Singapore Centre for Drug Discovery is an integral part of Lilly and as a result, has the strong backing of one of the world’s leading pharmaceutical companies.